SELLAS Life Sciences Stock Stumbles: What's Going On?
SELLAS Life Sciences shares declined as the company's Phase 3 leukemia study approaches final analysis.· summarised by Stockedin
SLS
Back to marketsAdd to watchlist Oct 28, 2025 · 2.00 USDOct 28, 2026 · 10.27 USD
SELLAS Life Sciences Group, Inc.
SLS · NasdaqCM
$10.28−15.57%(−1.89)
Yahoo Finance · delay unknown · USD · just in
Price history
Yahoo Finance · delay unknown · USD · 6 h old
Key figures
- Previous close
- 12.17
- Day range
- 9.71 – 12.44
- Volume
- 21.3M
- Market cap
- —
Information, not investment advice.
News about SELLAS Life Sciences Group, Inc.
Finnhub · delay unknown · 9 h old
Headline and publisher summary only; full articles stay with the source.